Carcinoma, Squamous Cell: all 1,779 studies

Page 17 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.

• Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck CancerTerminatedNCT01254734Not applicable
• Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerCompletedNCT01254617Phase 1
• Phase 1 and 2 Study of PX-866 and CetuximabCompletedNCT01252628Phase 1/2
• Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)TerminatedNCT01252329Not applicable
• Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
• TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck TumorsTerminatedNCT01245985Phase 2
• Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of LungCompletedNCT01236716Phase 2
• Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT01232374Phase 2
• Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of EsophagusCompletedNCT01225523Phase 1
• Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)CompletedNCT01220752Phase 2
• Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive TractCompletedNCT01211938Phase 2/3
• A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck CancerCompletedNCT01208883Phase 1
• A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell CarcinomaCompletedNCT01185158Phase 2
• InductionChemo-Radio-Antibody-TreatmentCompletedNCT01181401Phase 2
• Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01179360
• Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive TractWithdrawnNCT01175499Not applicable
• Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck CancersCompletedNCT01166542Phase 3
• Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or ChemotherapyTerminatedNCT01164566Not applicable
• L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerCompletedNCT01155609Not applicable
• A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of OesophagusStatus unknownNCT01151839Not applicable
• An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and NeckTerminatedNCT01142869
• Improve the Treatment of Thoracic Esophageal CancerCompletedNCT01137123Phase 3
• Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)Status unknownNCT01129154Phase 2
• A Phase 1 Study in Participants With Advanced CancerCompletedNCT01115790Phase 1
• Pharmacogenetic Response to Chemotherapy Induction for ORL CancersCompletedNCT01104714
• Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01086826Phase 3
• A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)CompletedNCT01080066
• Human Papillomavirus (HPV) in Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT01079546
• Chemoradiation and Panitumumab for Esophageal CancerCompletedNCT01077999Phase 2
• Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in KoreaCompletedNCT01075828
• Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell CarcinomaCompletedNCT01064921Phase 1
• Irinotecan Combined With Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer : a Single Center Prospective Clinical TrialStatus unknownNCT01051765Phase 2
• A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell CarcinomaCompletedNCT01046266Phase 1
• Human Papillomavirus on Oral Tissue, Saliva and SerumCompletedNCT01043328
• Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxCompletedNCT01020097Not applicable
• DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01017224
• Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01015664Phase 1/2
• A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the LungCompletedNCT00998192Phase 2
• Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCompletedNCT00995293Phase 3
• Treatment of Advanced Head and Neck CancerTerminatedNCT00982696Phase 2
• Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell CarcinomaCompletedNCT00968435Phase 2
• Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLCCompletedNCT00966472Phase 1
• Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck CancerActive, not recruitingNCT00957086Phase 3
• Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor RiskTerminatedNCT00937612Not applicable
• T-cell Based Immunotherapy for Head and Neck CancerWithdrawnNCT00937300Phase 1
• Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell CarcinomaWithdrawnNCT00934518Phase 2
• A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell CarcinomaCompletedNCT00933387Phase 2
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
• Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell CarcinomaTerminatedNCT00903461Phase 1
• Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck CancerTerminatedNCT00901537Phase 1
• A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western KenyaCompletedNCT00901173
• Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck CancerCompletedNCT00899054Phase 1/2
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerTerminatedNCT00896961Not applicable
• An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037CompletedNCT00884520Early Phase 1
• Analysis of Melanocytes (Pigment Cells) in Sun-Exposed SkinCompletedNCT00875381
• Detecting Lesions in the Oral Cavity With Thermal ImagingCompletedNCT00868725
• Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the LipCompletedNCT00868088Phase 4
• Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell CarcinomaStatus unknownNCT00855881Phase 2
• Phase II AK Study in Organ Transplant PatientsStatus unknownNCT00829192Phase 2
• A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck CancerCompletedNCT00824343Phase 2
• Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT00816634Phase 2
• Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00805012Phase 2
• Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00771641Phase 3
• Laryngeal Preservation in Pyriform Sinus CarcinomaCompletedNCT00770393Phase 2/3
• Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT00766480Not applicable
• Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck CarcinomaCompletedNCT00753038Phase 2
• The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation TherapyStatus unknownNCT00751543Not applicable
• Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00736619Phase 1
• Sexual Behavior in Head and Neck Cancer PatientsStatus unknownNCT00662662
• A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck CancerCompletedNCT00660218Phase 1/2
• Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)Status unknownNCT00652613Phase 2
• A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous CarcinomaStatus unknownNCT00642239Phase 4
• Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell CarcinomaStatus unknownNCT00634777Not applicable
• Trial of E10A in Head and Neck CancerStatus unknownNCT00634595Phase 2
• Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)WithdrawnNCT00627835Phase 1
• Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsCompletedNCT00625456Phase 1
• Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00623558Phase 2
• Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell CarcinomaCompletedNCT00620139
• Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00611754Phase 2
• Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell CarcinomaWithdrawnNCT00605709Phase 2
• A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)CompletedNCT00596258Phase 2
• Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomaCompletedNCT00596219Not applicable
• Head and Neck Cancer Screening and Serum RepositoryCompletedNCT00592371
• Safety Study of Modified Vaccinia Virus to CancerCompletedNCT00574977Phase 1
• Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)Status unknownNCT00563927Not applicable
• Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)TerminatedNCT00563862Not applicable
• RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the EsophagusTerminatedNCT00559351Phase 3
• TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHNCompletedNCT00539630Phase 3
• Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and NeckCompletedNCT00534950Not applicable
• Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckCompletedNCT00513383Phase 1
• Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell CancerCompletedNCT00507858Phase 1
• Dendritic Cell Vaccine for Head and Neck CancerWithdrawnNCT00492947Phase 1
• Acitretin Plasma Levels Under HemodialysisWithdrawnNCT00488384Phase 4
• Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and NeckCompletedNCT00474825Phase 1
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerCompletedNCT00458978Phase 2
• Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and NeckCompletedNCT00442455Phase 3
• Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00432315Phase 2

← Carcinoma, Squamous Cell overview